Study to Investigate the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Idarucizumab in Chinese Healthy Male and Female Volunteers Who Had Taken Dabigatran Etexilate and Whose Plasma Concentrations of Dabigatran Were at or Close to Steady State
Clinical trial NCT03086356 · COMPLETED
Trial details
- NCT number
- NCT03086356
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-10
- Primary completion
- 2017-09-12
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.